Income Taxes - Summary of Principal Components of Company's Deferred Tax Assets (Details) - USD ($) $ in Thousands |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|
| Deferred tax assets: | ||
| Federal, state and local net operating loss carryforwards | $ 28,880 | $ 28,857 |
| Research and development tax credits | 5,859 | 3,359 |
| Capitalized research and development costs | 9,640 | 0 |
| Stock-based compensation deductions | 3,840 | 2,616 |
| License fee deductions | 262 | 318 |
| Operating Lease Liability | 1,535 | 0 |
| Accrued expenses | 1,165 | 1,074 |
| Gross deferred tax assets | 51,181 | 36,224 |
| Less: valuation allowance | (49,689) | (36,224) |
| Total deferred tax assets | 1,492 | 0 |
| Deferred tax liabilities: | ||
| Operating lease assets | (1,492) | 0 |
| Net deferred tax assets | $ 0 | $ 0 |
| X | ||||||||||
- Definition Capitalized R&D costs No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets license fees deductions. No definition available.
|
| X | ||||||||||
- Definition Operating lease assets No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Present value of lessee's discounted obligation for lease payments from operating lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|